Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony
Contrasts EsoChecks powerful cell collection capabilities to cruder, decades-old technologies during comments on patient access to medical technology innovation NEW YORK, Feb. 15, 2024 /PRNewswire/...
Lishan Aklog Lucid Diagnostics Inc Exchange Commission National Cancer Institute Betrnet Case Western Reserve University Pavmed Inc
Source: marketscreener.com